KA
RMD icon

Kintegral Advisory’s ResMed RMD Stock Holding History

Kintegral Advisory’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$658K Sell
2,930
-130
-4% -$32.4K 0.06% 198
2025
Q4 		$737K Sell
3,060
-83
-3% -$21.2K 0.06% 198
2025
Q3 		$860K Sell
3,143
-14
-0.4% -$3.82K 0.07% 188
2025
Q2 		$815K Sell
3,157
-5
-0.2% -$1.19K 0.07% 198
2025
Q1 		$708K Sell
3,162
-11
-0.3% -$2.57K 0.07% 201
2024
Q4 		$726K Sell
3,173
-148
-4% -$35.6K 0.07% 199
2024
Q3 		$811K Sell
3,321
-43
-1% -$9.61K 0.07% 197
2024
Q2 		$644K Sell
3,364
-1,829
-35% -$371K 0.06% 211
2024
Q1 		$1.03M Sell
5,193
-16
-0.3% -$2.93K 0.1% 160
2023
Q4 		$896K Sell
5,209
-34
-0.6% -$5.22K 0.1% 167
2023
Q3 		$775K Sell
5,243
-3
-0.1% -$542 0.1% 174
2023
Q2 		$1.15M Hold
5,246
– – 0.14% 145
2023
Q1 		$1.15M Sell
5,246
-282
-5% -$61.2K 0.15% 145
2022
Q4 		$1.15M Buy
5,528
+1,666
+43% +$366K 0.15% 146
2022
Q3 		$843K Hold
3,862
– – 0.12% 151
2022
Q2 		$810K Buy
3,862
+82
+2% +$17.5K 0.11% 162
2022
Q1 		$917K Buy
3,780
+84
+2% +$20.3K 0.1% 165
2021
Q4 		$963K Hold
3,696
– – 0.1% 164
2021
Q3 		$974K Hold
3,696
– – 0.11% 158
2021
Q2 		$911K Hold
3,696
– – 0.11% 163
2021
Q1 		$717K Hold
3,696
– – 0.09% 185
2020
Q4 		$786K Hold
3,696
– – 0.11% 165
2020
Q3 		$634K Sell
3,696
-119
-3% -$22K 0.1% 174
2020
Q2 		$732K Hold
3,815
– – 0.12% 153
2020
Q1 		$562K Buy
3,815
+428
+13% +$68.2K 0.11% 164
2019
Q4 		$525K Hold
3,387
– – 0.1% 192
2019
Q3 		$458K Hold
3,387
– – 0.09% 201
2019
Q2 		$413K Hold
3,387
– – 0.08% 217
2019
Q1 		$352K Sell
3,387
-104
-3% -$10.7K 0.07% 228
2018
Q4 		$398K Buy
+3,491
New +$374K 0.12% 152

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kintegral Advisory's RMD Position: Q1 2026 in Review

Kintegral Advisory reduced its ResMed (RMD) stake by 4.2% in Q1 2026, selling an estimated $32.4K and leaving 2,930 shares worth $658K. The position accounts for 0.06% of the portfolio, ranked #198.

Kintegral Advisory first reported a position in RMD in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.15M in Q4 2022. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Kintegral Advisory held 2,930 shares of ResMed worth $658K as of Q1 2026.
  • Kintegral Advisory sold 130 ResMed shares in Q1 2026, an estimated $32.4K.
  • ResMed made up 0.06% of Kintegral Advisory's portfolio in Q1 2026, its #198 holding.
  • Kintegral Advisory first reported a position in ResMed in Q4 2018 and has held it in 30 quarters since.
  • Kintegral Advisory's ResMed position peaked at $1.15M in Q4 2022.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Kintegral Advisory's 13F filing for Q1 2026, filed 14 May 2026.